RxDoctor Payments Data

Stephanie Tang, MD

Emergency Medical Services · Los Angeles, CANPI 1720240526

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.2% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by AbbVie at 48.5% of the total. 2025 is the largest year on record at $361, more than ten times the $23 reported in 2019.

$1,154in general payments, 2019–2025

Across 35 payments — averaging $32.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$560
  • Gilead$268
  • Novo Nordisk$125
  • Abbott$111
  • Medtronic$67
  • W. L. Gore & Associates, Inc.$23

What the payments were for

  • Grants$676%
  • Food & beverage$1,08794%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie29$560
Gilead2$268
Novo Nordisk1$125
Abbott1$111
Medtronic1$67
W. L. Gore & Associates, Inc.1$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,154 in reported general payments places this provider in the 85th percentile of 103 emergency medical services providers in California.

See all emergency medical services providers in California

Medicare billing

Part B allowed, 2024
$91,072
Medicare patients
478
Services billed
565

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naloxone Hcl17$937
Cefdinir26$303
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav36$237
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen66$232
Ondansetron OdtOndansetron26$121
Cephalexin16$98
Ciprofloxacin Hcl12$76
Ibuprofen33$72
Prednisone30$50
Omeprazole16$48
Azithromycin15$39
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen21$37
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$36

Paid to pharmacies, not to this prescriber.

Other emergency medical services in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →